Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Balaxi Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Balaxi Pharmaceuticals Ltd Share Price Chart
Balaxi Pharmaceuticals Ltd Fundamentals
Traded Volume: 2,75,398
Market Cap(Cr): 206
Avg Traded Price 37.95
1 Year return -50.64%
Upper Circuit 39.5
Lower Circuit 36
P/E TTM 14.00
P/B Ratio 3.00
Traded Value(Cr) 102.83
EPS TTM 2.626
Book value 2.626
Dividend 0.00%
Balaxi Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Balaxi Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Balaxi Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -4.18%
1M -9.50%
3M -21.83%
1Y -50.64%
YTD -50.03%
Balaxi Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Balaxi Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 4.40L
Day Before Yesterday 63427.00
1W Avg 1.61L
1M Avg 73569.19
3M Avg 90206.48
Balaxi Pharmaceuticals Ltd Technical Details
Balaxi Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 36
Support 2 34
Support 3 32
Pivot Point : 38
Resistance 1 39
Resistance 2 41
Resistance 3 43
Balaxi Pharmaceuticals Ltd Corporate Actions
Balaxi Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Balaxi Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 30-May-2024 Type S Description share@1:5.00 Record Date 30-May-2024 Ratio 1:5.00
Ex-Date 01-Jul-2022 Type D Description 0.50/share@5.00% Record Date 04-Jul-2022 Ratio 5.00
Dividends
Announcement Date 01-Jul-2022 Ex Dividend Date 01-Jul-2022 Dividend(%) 5
Bonus
No Bonus has been declared by BALAXI
Splits
Record Date 30-May-2024 Split Date 30-May-2024 Face Value (Before/After) 10.00/2.00
Others
Rights No Rights has been declared by BALAXI
Balaxi Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Balaxi Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Balaxi Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Balaxi Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Balaxi Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -7.60 Mar 2024 -1.83 Mar 2023 -7.07
PARTICULARS Investing Activities Mar 2025 -24.98 Mar 2024 0.46 Mar 2023 -2.29
PARTICULARS Financing Activities Mar 2025 17.21 Mar 2024 27.55 Mar 2023 26.39
PARTICULARS Net Cash Flow Mar 2025 -15.37 Mar 2024 26.18 Mar 2023 17.03
Balaxi Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Balaxi Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 65.99%
Public 30.48%
Other Institutions 0.02%
FII 3.5%
Mutual Funds null%
About Balaxi Pharmaceuticals Ltd
Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942. The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017. The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%).The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders' hardware on August 08, 2018. The Company commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products from Financial Year 2018-19.Further, in February 2019, it kickstarted Food Products business by launching a range of biscuits under the brand `YAP'.The Company expanded its presence by establishing a central distribution warehouse in Guatemala, marking its entry into the third geography. This expansion helped in strengthening the distribution network and a wider customer base in 2019. In FY 2023, Company started operations in two Latin American Countries, i.e., Honduras and El Salvador and also started operations inthe Central African Republic.
Chairman / Executive Director / M D / Promoter
Ashish Maheshwari
Registered office 41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road, Kochi, Kerala, 682035
FAX :91-484-4032952/6596725
Background
Incorporation Year 1942
Face Value ₹2.00
Market Lot 1
FAQs on Balaxi Pharmaceuticals Ltd
How to buy Balaxi Pharmaceuticals Ltd shares on NSE?
To buy Balaxi Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Balaxi Pharmaceuticals Ltd share price today?
The Balaxi Pharmaceuticals Ltd share price on NSE is ₹37.34 today.
What is the market cap of Balaxi Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹206.14.
What is the PE & PB ratio of Balaxi Pharmaceuticals Ltd?
PE is 14 and PB is 3.
What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd shares?
Balaxi Pharmaceuticals Ltd stock price high: ₹85.58 Balaxi Pharmaceuticals Ltd stock price low: ₹35.67.